Spots Global Cancer Trial Database for A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Official Title: Open Phase IV Study to Assess the Impact of Tirbanibulin on the Wellbeing of Patients With Actinic Keratoses (TIRBASKIN)
Study ID: NCT05741294
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to assess treatment satisfaction on Day 57 in participants with Actinic Keratoses (AK) of the face or scalp following treatment with tirbanibulin ointment 1 percent (%) administered once daily for 5 consecutive days.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Almirall Investigational Site 3, Rimini, , Italy
Almirall Investigational Site 1, Valencia, , Spain
Almirall Investigational Site 2, Zaragoza, , Spain
Contact Details
Name: Alberto Lecchi
Affiliation: Almirall, SAS
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
